HEIDI NICHOLS: Open Payments
NPI 1972501138 · ADRIAN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 10 payments from 9 companies in 2025. Trend: 2023 $568 · 2024 $794 · 2025 $316
Food & beverage: $224Education: $92
| Company | Payments | Amount |
|---|---|---|
| Aveo Pharmaceuticals, Inc. | 1 | $92 |
| Janssen Biotech, Inc. | 2 | $47 |
| Ferring Pharmaceuticals Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Celgene Corporation | 1 | $31 |
| ABBVIE INC. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $21 |
| Eisai Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: FOTIVDA, ADSTILADRIN, FRUZAQLA, OPDUALAG, EPKINLY, RYBREVANT, TREMFYA, Xospata.
Industry payments across MI — which companies pay providers there.
